Ftse Mib
37.722,63
-3,45%
DAX
22.326,81
-3,51%
S&P 500
5.771,25
-1,34%
NASDAQ
18.136,38
-1,17%
Bitcoin
83.599,43
-2,89%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Apellis Pharmaceuticals Inc (APLS) Apellis Pharmaceuticals Inc (APLS) Notizie

Apellis Pharmaceuticals Inc

APLS
24,88
0,82 (3,41%)
Ultimo aggiornamento: 17:49:02
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/2/202513:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/2/202513:05GLOBEApellis Pharmaceuticals Reports Fourth Quarter and Full Year..
24/2/202513:00GLOBEApellis Pharmaceuticals to Present at the TD Cowen 45th..
20/2/202508:00GLOBEApellis and Sobi Announce EMA Validation of Indication..
14/2/202513:00GLOBEApellis Pharmaceuticals to Host Conference Call on February..
12/2/202519:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/2/202521:13EDGAR2Form 144 - Report of proposed sale of securities
04/2/202522:05GLOBEApellis Pharmaceuticals Announces Inducement Grants Under..
30/1/202518:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202518:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202518:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202518:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202518:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202518:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202518:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202518:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202518:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202521:42EDGAR2Form 144 - Report of proposed sale of securities
29/1/202521:26EDGAR2Form 144 - Report of proposed sale of securities
29/1/202521:22EDGAR2Form 144 - Report of proposed sale of securities
29/1/202521:18EDGAR2Form 144 - Report of proposed sale of securities
29/1/202521:17EDGAR2Form 144 - Report of proposed sale of securities
29/1/202521:16EDGAR2Form 144 - Report of proposed sale of securities
29/1/202521:16EDGAR2Form 144 - Report of proposed sale of securities
29/1/202521:12EDGAR2Form 144 - Report of proposed sale of securities
29/1/202521:11EDGAR2Form 144 - Report of proposed sale of securities
27/1/202522:00GLOBEApellis Receives Approval of SYFOVRE® (pegcetacoplan) in..
23/1/202521:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202521:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202521:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202521:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202521:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202521:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202521:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202521:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202521:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202521:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202522:00EDGAR2Form 144 - Report of proposed sale of securities
22/1/202521:56EDGAR2Form 144 - Report of proposed sale of securities
22/1/202521:52EDGAR2Form 144 - Report of proposed sale of securities
22/1/202521:51EDGAR2Form 144 - Report of proposed sale of securities
22/1/202521:45EDGAR2Form 144 - Report of proposed sale of securities
22/1/202521:45EDGAR2Form 144 - Report of proposed sale of securities
22/1/202521:44EDGAR2Form 144 - Report of proposed sale of securities
22/1/202521:43EDGAR2Form 144 - Report of proposed sale of securities
22/1/202521:42EDGAR2Form 144 - Report of proposed sale of securities
22/1/202521:39EDGAR2Form 144 - Report of proposed sale of securities
21/1/202522:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/1/202522:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/1/202522:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 24,17 Min: 23,77 Max: 24,92
Chiusura: 24,06

La tua Cronologia

NASDAQ
APLS
Apellis Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci